Home » Business, Health & Medicine, Pharmaceuticals & Biotech, Technology, World » Bioactive Wound Care Market to 4.9 USD Billion By 2020
“Use of Synthetic Protein Matrix and Growth Factors in Wound Healing will drive the future growth.”
Rapid Technological Innovations Will Accelerate the Growth of Bioactive Wound Care Market to 4.9 USD Billion By 2020

According to the market report, “Bioactive Wound Care Market Analysis: By First Line Interactive Dressing (Foams, Alginates, Hydrogel, Hydrocolloids, Collagen); By Second Line Interactive Dressing (Honey, Hydrofiber, Silicon, Silver) – With Forecast (2015 – 2020)”, the bioactive wound care market is projected to grow 4.9 USD Billion by 2020 at high CAGR.

Wound Care market has become one of the prominent sectors in Healthcare industry with market cap of $15 billion in 2014. The bioactive wound care market is still in the nascent stage with a huge opportunity to take over traditional wound care market. The primary objective of bioactive wound dressings is to reduce the treatment time which will save the overall cost for the patient. The relevance of bioactive wound dressings has increased over the years due to the proven efficacy of its positive effect on wound healing process.

North America has witnessed the highest number of clinical trials and remains the most profitable hub for bioactive wound care market. The bioactive wound care market consists of an extensive product line with different type of dressings such as Alginate based dressing, Collagen based dressing, Silver based dressing, Silicone based dressing and Honey based dressing. Each product type is designed to treat different type of wounds such as diabetic foot ulcers, venous leg ulcers, traumatic wounds and full thickness burns.

According to recent report by IndustryARC, the global bioactive wound care market will grow at CAGR of 5.56% and reach USD 4.9 Billion by 2020. The market for Silver dressings will be the major contributor in this growth. The demand for honey dressings will be relatively low due to the high uptake of better bioactive wound dressings such as alginate dressings and foam dressings.

Make an Inquiry at: http://www.industryarc.com/inquiry-before-buying.php?id=5344

The market for Bioactive Wound Care is analyzed on a global level. North America will lead the market during the forecast period till 2020 due to the high incidence of chronic and acute wounds, favorable healthcare reimbursement policies and growing geriatric population in countries such as U.S. and Canada.

Wound healing is a complex process and passes through several stages. The most essential part of treating chronic wounds is the scaffolding of extracellular matrix (ECM). ECM provides the properties of elasticity and tensile strength to the skin. It is made up of different proteins such as Collagen, fibronectins, elastins and laminins. Extracellular matrix is of high importance as it interacts with the skin cells to fasten the process of wound closure.

In the geriatric population, the issue of delayed wound healing or wound perpetuation becomes evident as the extracellular matrix gets damaged. The future focus will be hence be on developing synthetic protein matrix which will assist in scaffolding.  The synthetic protein matrix can replace the dysfunctional extra cellular matrix. The innovation will add a new dimension to the bioactive wound care and Tissue Therapies Limited is developing bioactive wound care products based on this technology.

Use of Synthetic Protein Matrix and Growth Factors in Wound Healing will drive the future growth.

In the recent past, extensive research has been conducted for understanding the efficacy of growth factors in treatment of chronic wounds. Growth Factors are extracted from human tissue or animal tissue. However, there has been a lot of debate on the use of growth factors. The issue of safety and cost has affected the translation of growth factors into clinical trials. The major problem associated with the use of growth factors is that optimized delivery systems are required for effective wound healing.

The focus is on developing recombinant growth factors. The advantage with recombinant growth factors is that the risk associated with disease transmission is reduced to a great extent. There are growth factors such as bFGF, TGF-beta 3, EGF and VEGF, which have been proven to be effective in wound healing. There is a need to conduct more number of clinical trials to analyze the positive effect of growth factors in wound healing.

PDF Sample at: http://www.industryarc.com/pdfdownload.php?id=5344

The companies who exist in the bioactive wound Care market are ready to capitalize upon the opportunity to increase customer base.

The major companies in the market are:

  • 3M Healthcare
  • Smith & Nephew plc
  • Convatec Inc.
  • Covidien
  • Acelity, Inc.

New products are being designed by companies to provide improved healing for chronic wounds such as diabetic foot ulcers and venous leg ulcers. 3M Tegaderm Alginate Ag Silver dressing for example, has antimicrobial properties of silver which helps to treat colonized wounds. The soft-gelling absorbency provides moist surrounding for fast healing. Such dressings are particularly useful for treating necrotic wounds and abrasions.

Media Contact
Company Name: IndustryARC
Contact Person: Mr. Sanjay Matthews
Email: sales@industryarc.com
Phone: 1-614-588-8538 (Ext: 101)
Country: United States
Website: http://www.industryarc.com

Comments are closed.